|Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial|
C Koh, L Canini, H Dahari, X Zhao, SL Uprichard, V Haynes-Williams, ...
The Lancet Infectious Diseases 15 (10), 1167-1174, 2015
|Rates of and factors associated with placebo response in trials of pharmacotherapies for nonalcoholic steatohepatitis: systematic review and meta-analysis|
MAT Han, O Altayar, S Hamdeh, V Takyar, Y Rotman, O Etzion, ...
Clinical Gastroenterology and Hepatology 17 (4), 616-629. e26, 2019
|Magnetic resonance elastography shear wave velocity correlates with liver fibrosis and hepatic venous pressure gradient in adults with advanced liver disease|
AM Gharib, MAT Han, EG Meissner, DE Kleiner, X Zhao, M McLaughlin, ...
BioMed research international 2017, 2017
|Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD)|
MAT Han, R Saouaf, W Ayoub, T Todo, E Mena, M Noureddin
Expert review of clinical pharmacology 10 (4), 379-390, 2017
|The balance of type 1 and type 2 immune responses in the contexts of hepatitis B infection and hepatitis D infection|
EC Townsend, GY Zhang, R Ali, M Firke, MS Moon, MAT Han, B Fram, ...
Journal of gastroenterology and hepatology 34 (4), 764-775, 2019
|392 Post-Infectious Irritable Bowel Syndrome in Patients Undergoing Fecal Microbiota Transplantation for Recurrent Clostridium difficile Colitis|
S Garg, Y Song, MAT Han, M Girotra, WF Fricke, S Dutta
Gastroenterology 146 (5), S-83-S-84, 2014
|MR elastography‐based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study|
MAT Han, A Vipani, N Noureddin, K Ramirez, J Gornbein, R Saouaf, ...
Liver International 40 (9), 2242-2251, 2020
|Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection|
L Canini, C Koh, SJ Cotler, SL Uprichard, MA Winters, MAT Han, ...
Hepatology communications 1 (4), 288-292, 2017
|Diversity in NAFLD: a review of manifestations of nonalcoholic fatty liver disease in different ethnicities globally|
MAT Han, Q Yu, Z Tafesh, N Pyrsopoulos
Journal of Clinical and Translational Hepatology 9 (1), 71, 2021
|A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C|
C Koh, P Dubey, MAT Han, PJ Walter, HM Garraffo, P Surana, ...
Antiviral research 163, 149-155, 2019
|Noninvasive tests (NITs) for hepatic fibrosis in fatty liver syndrome|
Life 10 (9), 198, 2020
|Accounting for the Placebo Effect and Optimizing Outcomes in Clinical Trials of Nonalcoholic Steatohepatitis (NASH)|
N Noureddin, MAT Han, N Alkhouri, M Noureddin
Current Hepatology Reports 19 (1), 63-69, 2020
|Liver Functional Assessment by Dual Cholate Testing Is Strongly Correlated with Direct Portal Pressure and Ishak Fibrosis Stage|
O Etzion, R Ali, GY Zhang, EC Townsend, C Koh, E Levy, VK Takyar, ...
Hepatology 66, 1036A-1037A, 2017
|Modeling hepatitis delta virus dynamics during ritonavir boosted lonafarnib treatment-the LOWR HDV-3 study|
P Dubey, C Koh, P Surana, SL Uprichard, MAT Han, N Fryzek, D Kapuria, ...
Hepatology 66, 21A-21A, 2017
|Fibrosis changes in the placebo arm of NASH clinical trials|
O Altayar, N Noureddin, MAT Han, MH Murad, M Noureddin
Clinical Gastroenterology and Hepatology 17 (11), 2387, 2019
|The performance of MRI-proton density fat fraction (PDFF) and MR elastography (MRE) in diagnosing nonalcoholic steatohepatitis (NASH) noninvasively|
M Noureddin, V Sundaram, WS Ayoub, MAT Han, JF Grotts, R Saouaf, ...
Hepatology 68, 1327A-1328A, 2018
|Abnormal liver tests are inaccurate for diagnosis of chronic hepatic graft versus host disease in critically ill patients|
MAT Han, N Samala, BS Rizvi, O Etzion, EC Wright, R Patel, ...
Hepatology 64, 182A-182A, 2016
|Liver Involvement in Turner's Syndrome, Is Associated with Extra Hepatic Disease Manifestations: 1720|
O Etzion, T Heller, M Han, R Patel, C Koh, D Kleiner, O Mousa, R Loomba, ...
Hepatology 62, 2015
|Liver Enzymes Elevation In The Setting Of Chronic Graft-Versus-Host Disease Is A Non Specific Marker Of Inflammation That Does Not Accurately Predict Disease Related Hepatic …|
M Han, N Samala, B Rizvi, K Wilkins, O Etzion, E Jones, C Koh, D Kleiner, ...
Hepatology 62, 2015
|An Innovative Approach to Resident Scheduling: Use of a Point-Based System to Account for Resident Preferences|
RTP Chow, S Tamhane, M Zhang, LA Fisher, J Yoon, S Sehgal, ...
Journal of graduate medical education 7 (3), 451, 2015